Research3h ago
First AI-Designed Vaccine Enters Human Trials
A vaccine designed entirely by artificial intelligence has entered its first human clinical trials. Researchers used generative AI to engineer a protein that mimics a virus, bypassing traditional trial-and-error methods. This shift accelerates the development timeline for new immunizations. Practitioners can now expect faster transitions from digital design to patient testing for complex pathogens.